Navigation Links
Genmab's Financial Calendar for 2008
Date:1/31/2008

COPENHAGEN, Denmark, January 31 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announces its financial calendar for 2008 as follows:

EVENT DATE

Publication of the Annual Report for 2007 Monday, March 31, 2008

Annual General Meeting 2008 Wednesday, April 23, 2008

Publication of the Interim Report for the Wednesday, May 28, 2008

first quarter 2008

Publication of the Interim Report for the Wednesday, August 27, 2008

first half 2008

Publication of the Interim Report for the Wednesday, October 29, 2008

first nine months 2008

Publication of the financial reports will be after market close on the date of the event.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
2. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
3. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
4. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
6. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
7. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
8. Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... hospitals with surgery validation using its Stratasys Objet24 and Objet30 ... surgery on 3D printed models prior to operations reduces theatre ... effective aid for both patient and surgeon   ... a global leader of 3D printing and additive manufacturing solutions, ...
(Date:8/26/2014)... AVENTURA. Fla. , Aug. 26, 2014 /PRNewswire/ ... trades under the symbol (NUUU) has two (2) ... Inc. Our two subsidiaries harness scientifically advanced technology ... NUUU,s Renuell Int,l, Inc. ... breakthrough anti-aging skin care products that is made ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... The Renewable Energy ... promising locations for renewable energy projects. ,The Atlas is the first tool of its kind ... select from a suite of renewable energy options including biomass, efficiency, geothermal, hydroelectric, solar and ... (PRWEB) ...
... ... Environmental Sustainability (EStar) award from the U.S. Department of Energy,s (DOE) Office of Science. ... Argonne, ... Gene/P supercomputer was recognized with an Environmental Sustainability (EStar) award from the U.S. Department ...
... ... of 2007 and to enhance patient safety with complete part traceability, can now use ... coding, scan and software tracking of each part and batch, including all leak test, ... ...
Cached Biology Technology:Vermont Launches Renewable Energy Atlas 2Vermont Launches Renewable Energy Atlas 3Vermont Launches Renewable Energy Atlas 4EStar Award Recognizes Innovative Supercomputer Cooling 2EStar Award Recognizes Innovative Supercomputer Cooling 3InterTech Development Company UDI System Announced 2
(Date:8/25/2014)... predominant strain of community-acquired methicillin-resistant Staphylococcus aureus ... East and northern Africa derived from a single ... this week in mBio , the online ... , CA-MRSA refers to MRSA infections occurring in ... which are typically skin infections, can be transmitted ...
(Date:8/25/2014)... deficiency is one of the most widespread causes of ... the United States are plagued by boron deficient soil ... supplement their soil with boron; however, little is known ... essential nutrient. Now, researchers at the University of Missouri ... development and reproduction in corn plants. Scientists anticipate that ...
(Date:8/25/2014)... that toxic effects of substances known as endocrine ... human-made materials, can pass from one generation to ... with ancestral exposure to EDC may show especially ... new study by researchers from The University of ... and female rats are affected differently by ancestral ...
Breaking Biology News(10 mins):Common European MRSA originated in Africa 2Researchers find boron facilitates stem cell growth and development in corn 2Exposure to toxins makes great granddaughters more susceptible to stress 2
... CITY People at risk for a certain form of ... better chance at surviving or even avoiding the diseases, thanks ... Institute at LDS Hospital. The Intermountain Heathcare group of ... cost-effective way to identify patients who may have Lynch syndrome, ...
... of researchers at the Department of Energy,s BioEnergy Science ... controls ethanol production capacity in a microorganism. This discovery ... that produce higher concentrations of ethanol at lower costs. ... the scientific discoveries of its labs and research centers ...
... study by an international team including professor John Graves of ... species of tunas and billfishes are threatened and in need ... issue of Science magazine,s Policy Forumis the first ... of the International Union for Conservation of Nature (IUCN). ,The ...
Cached Biology News:Study: New process that can save at-risk cancer patients is effective and significantly less costly 2Study: New process that can save at-risk cancer patients is effective and significantly less costly 3Single, key gene discovery could streamline production of biofuels 2Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3
Acetylcholinesterase from human and monkey....
...
... Dye runs faster than Bromophenol blue,or ... gels.,Orange G dye migrates with DNA ... migration at this size,prevents the obscuring ... the front of DNA migration.,The Orange ...
... Gel loading solution, ... for non-denaturing polyacrylamide and ... nucleic acids and offers ... tracking dyes (bromphenol blue ...
Biology Products: